Transplant Diagnostics Market by Technology, Product, Application, Type, End User - Global Forecast to 2023

  • ID: 4586300
  • Report
  • Region: Global
  • 222 Pages
  • Markets and Markets
1 of 5
The Global Transplant Diagnostics Market is Projected to Reach USD 4.91 Billion by 2023 from USD 3.44 Billion in 2018, at a CAGR of 7.4%

FEATURED COMPANIES

  • Biofortuna
  • Bio-Rad Laboratories
  • Gendx
  • Illumina
  • Luminex
  • Omixon
  • MORE

“The transplant diagnostics market projected to grow at a CAGR of 7.4%.”

The global transplant diagnostics market is projected to reach USD 4.91 billion by 2023 from USD 3.44 billion in 2018, at a CAGR of 7.4%. Increasing number of transplantation procedures, technological advancements in the field of transplant diagnostics, increasing public-private funding for target research activities, and growing burden of infectious diseases are some of the factors responsible for the growth of this market. However, the high procedural cost for next-generation sequencing (NGS) and PCR-based diagnostics assays and limited availability of reimbursements for target procedures are expected to limit the optimal adoption of transplant diagnostics during the forecast period.

“The molecular assay technologies segment is poised to be the fastest-growing during the forecast period.”

On the basis of technology, the transplant diagnostics market is segmented into molecular (PCR based assay and sequencing-based assay technologies) and non-molecular assays. The molecular assay technology segment is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to the technological benefits of molecular assays such as low turnaround time, high procedural efficacy, study of multiple samples, and real-time sample analysis.

“Asia Pacific is expected to register the highest growth rate during the forecast period.”

Geographically, the transplant diagnostics market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. The highest CAGR for the APAC transplant diagnostics market can be attributed to the increasing adoption of cutting-edge diagnostic technologies among medical professionals, rapid rise in geriatric population (especially in Japan and China), and universal government healthcare coverage in Japan (including for transplantation & related diagnostic procedures).

Breakdown of supply-side primary interviews: by company type, designation, and region:

  • By Company Type - Tier 1 - 25%, Tier 2 - 30% and Tier 3 - 45%
  • By Designation - C-level - 26%, Director-level - 30%, Others - 44%
  • By Region - North America - 34%, Europe - 26%, APAC - 23%, RoW - 17%

The global transplant diagnostics market is competitive, with a large number of global and local players. In 2017, the market was dominated by Thermo Fisher Scientific Inc. (US), Bio-Rad Laboratories, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), and Immucor, Inc. (US). Product launches, market expansions, strategic acquisitions, and partnerships, agreements, & collaborations were the major strategies adopted by market players to achieve growth in the market.

Research Coverage:

This report studies the transplant diagnostics market based on technology, product, transplant type, application, and end user. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for the market leaders. Furthermore, the report analyzes micro-markets with respect to their individual growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four main regions.

Reasons to Buy the Report:

From an insights perspective, this research report has focused on various levels of analysis—industry trends, market share analysis of top players, and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging and high-growth segments of the transplant diagnostics market, and high-growth regions and countries and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn help firms garner greater market shares. Firms purchasing the report could use any one or a combination of the below mentioned five strategies for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on product portfolios offered by the major players in the transplant diagnostics market. The report analyzes the transplant diagnostics market based on technology, product, transplant type, application, end user, and region
  • Product Development: Detailed insights on the research and development activities and product launches in the transplant diagnostics market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various transplant diagnostics across geographies.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the transplant diagnostics market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the transplant diagnostics market
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Biofortuna
  • Bio-Rad Laboratories
  • Gendx
  • Illumina
  • Luminex
  • Omixon
  • MORE

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
1.3.3 Years Considered for the Study
1.4 Currency Used for the Study
1.5 Major Market Stakeholders

2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.2 Primary Data
2.2 Market Size Estimation
2.2.1 Product-Based Market Estimation
2.2.2 Procedure Based Market Estimation
2.2.3 Primary Research Validation
2.3 Data Triangulation
2.4 Research Assumptions
2.5 Research Limitations

3 Executive Summary

4 Premium Insights
4.1 Transplant Diagnostics Market Overview
4.2 Market, By Technology
4.3 Regional Analysis: Market, By Application
4.4 Asia Pacific: Market, By End User, 2018
4.5 Regional Analysis: Market, By Product & Service
4.6 Regional Analysis: Market, By Transplant Type
4.7 Transplant Diagnostics Market, By Country

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Key Market Drivers
5.2.1.1 Increasing Number of Transplant Procedures
5.2.1.2 Technological Advancements in the Field of Transplant Diagnostics
5.2.1.3 Increasing Public-Private Funding for Target Research Activities
5.2.1.4 Growing Burden of Infectious Diseases
5.2.2 Key Market Restraints
5.2.2.1 High Procedural Cost of NGS and PCR-Based Diagnostic Assays
5.2.2.2 Limited Reimbursements for Target Procedures
5.2.3 Key Market Opportunities
5.2.3.1 Rising Adoption of Cross-Matching and Chimerism Testing During Pre- & Post-Transplantation
5.2.3.2 Increasing Public Awareness About Organ Donation and Transplantation Across Emerging Countries
5.2.4 Key Market Challenges
5.2.4.1 Significant Gap Between the Number of Organ Donors and Organs Required Annually
5.2.4.2 Procedural and Technical Limitations Associated With Donor-Recipient Screening

6 Transplant Diagnostics Market, By Product and Services
6.1 Introduction
6.2 Reagents and Consumables
6.3 Instruments
6.4 Software and Services

7 Transplant Diagnostics Market, By Technology
7.1 Introduction
7.2 Molecular Assays
7.2.1 PCR-Based Molecular Assays
7.2.1.1 Real-Time PCR
7.2.1.2 Sequence-Specific Primer-PCR
7.2.1.3 Sequence-Specific Oligonucleotide-PCR
7.2.1.4 Other PCR-Based Molecular Assays
7.2.2 Sequencing-Based Molecular Assays
7.2.2.1 Sanger Sequencing
7.2.2.2 Next-Generation Sequencing
7.2.2.3 Other Sequencing Molecular Assays
7.3 Non-Molecular Assays

8 Transplant Diagnostics Market, By Transplant Type
8.1 Introduction
8.2 Solid Organ Transplantation
8.2.1 Kidney Transplantation
8.2.2 Liver Transplantation
8.2.3 Heart Transplantation
8.2.4 Lung Transplantation
8.2.5 Pancreas Transplantation
8.2.6 Other Organ Transplantations
8.3 Stem Cell Transplantation
8.4 Soft Tissue Transplantation

9 Transplant Diagnostics Market, By Application
9.1 Introduction
9.2 Diagnostic Applications
9.2.1 Pre-Transplantation Diagnostics
9.2.1.1 Infectious Disease Testing
9.2.1.2 Histocompatibility Testing
9.2.1.3 Blood Profiling
9.2.2 Post-Transplantation Diagnostics
9.3 Research Applications

10 Transplant Diagnostics Market, By End User
10.1 Introduction
10.2 Independent Reference Laboratories
10.3 Hospitals & Transplant Centers
10.4 Research Laboratories & Academic Institutes

11 Transplant Diagnostics Market, By Region
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 France
11.3.4 Rest of Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Rest of Asia Pacific
11.5 Rest of the World

12 Competitive Landscape
12.1 Overview
12.2 Market Share Analysis
12.3 Competitive Scenario
12.3.1 Key Product Launches and Enhancements (2014 to 2018)
12.3.2 Key Agreements, Partnerships, and Collaborations (2014 to 2018)
12.3.3 Major Acquisitions (2014 to 2018)
12.3.4 Key Expansions (2014 to 2018)

13 Company Profiles
(Business Overview, Products Offered, Recent Developments, MnM View)*
13.1 Introduction
13.2 Becton, Dickinson and Company
13.3 Biofortuna
13.4 Biomérieux SA
13.5 Bio-Rad Laboratories
13.6 Caredx
13.7 F. Hoffman-La Roche Limited
13.8 Gendx
13.9 Hologic
13.10 Illumina
13.11 Immucor
13.12 Luminex
13.13 Merck KGaA
13.14 Omixon
13.15 Qiagen
13.16 Thermo Fisher Scientific

14 Appendix
14.1 Discussion Guide
14.2 Knowledge Store: Subscription Portal
14.3 Introducing RT: Real-Time Market Intelligence
14.4 Available Customizations
14.5 Related Reports
14.6 Author Details

List of Tables
Table 1 Public-Private Investments and Research Grants for the Development of Transplant Diagnostic Products, 2015-2018
Table 2 Cost of Assays for Major NGS/PCR-Based Genomic Tests in Europe (As of 2014)
Table 3 Medical Reimbursements for Transplantation Procedures in the US (2017)
Table 4 Transplant Diagnostics Market, By Product & Services, 2016-2023 (USD Million)
Table 5 Market for Reagents and Consumables, By Region, 2016-2023 (USD Million)
Table 6 Market for Instruments, By Region, 2016-2023 (USD Million)
Table 7 Market for Software and Services, By Region, 2016-2023 (USD Million)
Table 8 Market, By Technology, 2016-2023 (USD Million)
Table 9 Market for Molecular Assays, By Type, 2016-2023 (USD Million)
Table 10 Market for Molecular Assays, By Region, 2016-2023 (USD Million)
Table 11 Transplant Diagnostics Market for PCR-Based Molecular Assays, By Type, 2016-2023 (USD Million)
Table 12 Market for PCR-Based Molecular Assays, By Product, 2016-2023 (USD Million)
Table 13 Market for PCR-Based Molecular Assays, By Application, 2016-2023 (USD Million)
Table 14 Market for PCR-Based Molecular Assays, By End User, 2016-2023 (USD Million)
Table 15 Market for PCR-Based Molecular Assays, By Region, 2016-2023 (USD Million)
Table 16 Market for Real-Time PCR, By Region, 2016-2023 (USD Million)
Table 17 Market for Sequence-Specific Primer-PCR, By Region, 2016-2023 (USD Million)
Table 18 Transplant Diagnostics Market for Sequence-Specific Oligonucleotide-PCR, By Region, 2016-2023 (USD Million)
Table 19 Market for Other PCR-Based Molecular Assays, By Region, 2016-2023 (USD Million)
Table 20 Market for Sequencing-Based Molecular Assays, By Type, 2016-2023 (USD Million)
Table 21 Market for Sequencing-Based Molecular Assays, By Product, 2016-2023 (USD Million)
Table 22 Market for Sequencing-Based Molecular Assays, By Application, 2016-2023 (USD Million)
Table 23 Market for Sequencing-Based Molecular Assays, By End User, 2016-2023 (USD Million)
Table 24 Market for Sequencing-Based Molecular Assays, By Region, 2016-2023 (USD Million)
Table 25 Market for Sanger Sequencing, By Region, 2016-2023 (USD Million)
Table 26 Market for Next-Generation Sequencing, By Region, 2016-2023 (USD Million)
Table 27 Market for Other Sequencing Molecular Assays, By Region, 2016-2023 (USD Million)
Table 28 Transplant Diagnostics Market for Non-Molecular Assays, By Product, 2016-2023 (USD Million)
Table 29 Market for Non-Molecular Assays, By Application, 2016-2023 (USD Million)
Table 30 Market for Non-Molecular Assays, By End User, 2016-2023 (USD Million)
Table 31 Market for Non-Molecular Assays, By Region, 2016-2023 (USD Million)
Table 32 Market, By Transplant Type, 2016-2023 (USD Million)
Table 33 Solid Organ Transplantation Market, By Type, 2016-2023 (USD Million)
Table 34 Solid Organ Transplantation Market, By Region, 2016-2023 (USD Million)
Table 35 Kidney Transplantation Market, By Region, 2016-2023 (USD Million)
Table 36 Liver Transplantation Market, By Region, 2016-2023 (USD Million)
Table 37 Heart Transplantation Market, By Region, 2016-2023 (USD Million)
Table 38 Lung Transplantation Market, By Region, 2016-2023 (USD Million)
Table 39 Pancreas Transplantation Market, By Region, 2016-2023 (USD Million)
Table 40 Other Organ Transplantations Market, By Region, 2016-2023 (USD Million)
Table 41 Stem Cell Transplantation Market, By Region, 2016-2023 (USD Million)
Table 42 Soft Tissue Transplantation Market, By Region, 2016-2023 (USD Million)
Table 43 Transplant Diagnostics Market, By Application, 2016-2023 (USD Million)
Table 44 Market for Diagnostic Applications, By Type, 2016-2023 (USD Million)
Table 45 Market for Diagnostic Applications, By Region, 2016-2023 (USD Million)
Table 46 Transplant Diagnostics Market for Pre-Transplantation Diagnostics, By Type, 2016-2023 (USD Million)
Table 47 Market for Pre-Transplantation Diagnostics, By Region, 2016-2023 (USD Million)
Table 48 Transplant Diagnostics Market for Infectious Disease Testing, By Region, 2016-2023 (USD Million)
Table 49 Market for Histocompatibility Testing, By Region, 2016-2023 (USD Million)
Table 50 Market for Blood Profiling, By Region, 2016-2023 (USD Million)
Table 51 Market for Post-Transplantation Diagnostics, By Region, 2016-2023 (USD Million)
Table 52 Transplant Diagnostics Market for Research Applications, By Region, 2016-2023 (USD Million)
Table 53 Market, By End User, 2016-2023 (USD Million)
Table 54 Market for Independent Reference Laboratories, By Region, 2016-2023 (USD Million)
Table 55 Transplant Diagnostics Market for Hospitals & Transplant Centers, By Region, 2016-2023 (USD Million)
Table 56 Market for Research Laboratories & Academic Institutes, By Region, 2016-2023 (USD Million)
Table 57 Transplant Diagnostics Market, By Region, 2016-2023 (USD Million)
Table 58 Total Number of Solid Organ Transplantations Across Key Countries (2016)
Table 59 North America: Transplant Diagnostics Market, By Country, 2016-2023 (USD Million)
Table 60 North America: Market, By Technology, 2016-2023 (USD Million)
Table 61 North America: Market for PCR-Based Molecular Assays, By Type, 2016-2023 (USD Million)
Table 62 North America: Market for Sequencing-Based Molecular Assays, By Type, 2016-2023 (USD Million)
Table 63 North America: Market, By Product and Services, 2016-2023 (USD Million)
Table 64 North America: Transplant Diagnostics Market, By Application, 2016-2023 (USD Million)
Table 65 North America: Market, By Transplant Type, 2016-2023 (USD Million)
Table 66 North America: Transplant Diagnostics Market, By End User, 2016-2023 (USD Million)
Table 67 US: Market, By Technology, 2016-2023 (USD Million)
Table 68 US: Transplant Diagnostics Market for PCR-Based Molecular Assays, By Type, 2016-2023 (USD Million)
Table 69 US: Market for Sequencing-Based Molecular Assays, By Type, 2016-2023 (USD Million)
Table 70 Canada: Transplant Diagnostics Market, By Technology, 2016-2023 (USD Million)
Table 71 Canada: Market for PCR-Based Molecular Assays, By Type, 2016-2023 (USD Million)
Table 72 Canada: Transplant Diagnostics Market for Sequencing-Based Molecular Assays, By Type, 2016-2023 (USD Million)
Table 73 Europe: Market, By Country, 2016-2023 (USD Million)
Table 74 Europe: Transplant Diagnostics Market, By Technology, 2016-2023 (USD Million)
Table 75 Europe: Market for PCR-Based Molecular Assays, By Type, 2016-2023 (USD Million)
Table 76 Europe: Transplant Diagnostics Market for Sequencing-Based Molecular Assays, By Type, 2016-2023 (USD Million)
Table 77 Europe: Transplant Diagnostics Market, By Product and Services, 2016-2023 (USD Million)
Table 78 Europe: Market, By Application, 2016-2023 (USD Million)
Table 79 Europe: Market, By Transplant Type, 2016-2023 (USD Million)
Table 80 Europe: Market, By End User, 2016-2023 (USD Million)
Table 81 Germany: Transplant Diagnostics Market, By Technology, 2016-2023 (USD Million)
Table 82 Germany: Market for PCR-Based Molecular Assays, By Type, 2016-2023 (USD Million)
Table 83 Germany: Transplant Diagnostics Market for Sequencing-Based Molecular Assays, By Type, 2016-2023 (USD Million)
Table 84 Organ Transplantations Performed in the UK, 2013 vs 2015
Table 85 UK: Market, By Technology, 2016-2023 (USD Million)
Table 86 UK: Market for PCR-Based Molecular Assays, By Type, 2016-2023 (USD Million)
Table 87 UK: Market for Sequencing-Based Molecular Assays, By Type, 2016-2023 (USD Million)
Table 88 France: Transplant Diagnostics Market, By Technology, 2016-2023 (USD Million)
Table 89 France: Market for PCR-Based Molecular Assays, By Type, 2016-2023 (USD Million)
Table 90 France: Transplant Diagnostics Market for Sequencing-Based Molecular Assays, By Type, 2016-2023 (USD Million)
Table 91 RoE: Market, By Technology, 2016-2023 (USD Million)
Table 92 RoE: Market for PCR-Based Molecular Assays, By Type, 2016-2023 (USD Million)
Table 93 RoE: Transplant Diagnostics Market for Sequencing-Based Molecular Assays, By Type, 2016-2023 (USD Million)
Table 94 Asia Pacific: Market, By Country, 2016-2023 (USD Million)
Table 95 Asia Pacific: Market, By Technology, 2016-2023 (USD Million)
Table 96 Asia Pacific: Market for PCR-Based Molecular Assays, By Type, 2016-2023 (USD Million)
Table 97 Asia Pacific: Transplant Diagnostics Market for Sequencing-Based Molecular Assays, By Type, 2016-2023 (USD Million)
Table 98 Asia Pacific: Market, By Product and Services, 2016-2023 (USD Million)
Table 99 Asia Pacific: Transplant Diagnostics Market, By Application, 2016-2023 (USD Million)
Table 100 Asia Pacific: Market, By Transplant Type, 2016-2023 (USD Million)
Table 101 Asia Pacific: Market, By End User, 2016-2023 (USD Million)
Table 102 Japan: Market, By Technology, 2016-2023 (USD Million)
Table 103 Japan: Market for PCR-Based Molecular Assays, By Type, 2016-2023 (USD Million)
Table 104 Japan: Transplant Diagnostics Market for Sequencing-Based Molecular Assays, By Type, 2016-2023 (USD Million)
Table 105 Organ Transplantations Performed in China, 2013 vs 2015
Table 106 China: Market, By Technology, 2016-2023 (USD Million)
Table 107 China: Market for PCR-Based Molecular Assays, By Type, 2016-2023 (USD Million)
Table 108 China: Transplant Diagnostics Market for Sequencing-Based Molecular Assays, By Type, 2016-2023 (USD Million)
Table 109 India: Market, By Technology, 2016-2023 (USD Million)
Table 110 India: Market for PCR-Based Molecular Assays, By Type, 2016-2023 (USD Million)
Table 111 India: Transplant Diagnostics Market for Sequencing-Based Molecular Assays, By Type, 2016-2023 (USD Million)
Table 112 Solid-Organ Transplantations Performed in the RoAPAC, 2013 vs 2016
Table 113 RoAPAC: Market, By Technology, 2016-2023 (USD Million)
Table 114 RoAPAC: Transplant Diagnostics Market for PCR-Based Molecular Assays, By Type, 2016-2023 (USD Million)
Table 115 RoAPAC: Market for Sequencing-Based Molecular Assays, By Type, 2016-2023 (USD Million)
Table 116 RoW: Transplant Diagnostics Market, By Technology, 2016-2023 (USD Million)
Table 117 RoW: Transplant Diagnostics Market for PCR-Based Molecular Assays, By Type, 2016-2023 (USD Million)
Table 118 RoW: Market for Sequencing-Based Molecular Assays, By Type, 2016-2023 (USD Million)
Table 119 RoW: Transplant Diagnostics Market, By Product and Services, 2016-2023 (USD Million)
Table 120 RoW: Market, By Application, 2016-2023 (USD Million)
Table 121 RoW: Market, By Transplant Type, 2016-2023 (USD Million)
Table 122 RoW: Transplant Diagnostics Market, By End User, 2016-2023 (USD Million)

List of Figures
Figure 1 Research Design
Figure 2 Breakdown of Primaries: Global Transplant Diagnostics Market
Figure 3 Market Size Estimation: Market
Figure 4 Data Triangulation Methodology
Figure 5 Reagents and Consumables Segment to Account for the Largest Share of the Market in 2023
Figure 6 Sequence-Specific Oligonucleotides-PCR Segment Will Continue to Dominate the Transplant Diagnostics Market in 2023
Figure 7 Solid Organ Transplantation Segment to Account for the Largest Share of the Market in 2018
Figure 8 Infectious Disease Testing Segment to Account for the Largest Share of the Market in 2018
Figure 9 Independent Reference Laboratories Segment to Register the Highest Growth During the Forecast Period
Figure 10 Geographical Snapshot of the Market
Figure 11 Growth in Transplantation Procedures to Drive the Demand for Transplant Diagnostic Products Till 2023
Figure 12 PCR-Based Molecular Assays to Dominate the Market, By Technology, During the Forecast Period
Figure 13 Infectious Disease Testing and Histocompatibility Testing Segments to Witness High Growth in the Asia Pacific Market
Figure 14 Independent Reference Laboratories Will Dominate the Asia Pacific Transplant Diagnostics End-User Market in 2018
Figure 15 North America is Estimated to Be the Largest Market for All Products & Services Segments in the Transplant Diagnostics Market in 2018
Figure 16 Kidney Transplantation Segment to Dominate the Market During the Forecast Period
Figure 17 China and India is Estimated to Be the Fastest-Growing Transplant Diagnostics Market
Figure 18 Transplant Diagnostics Market: Drivers, Restraints, Opportunities, and Challenges
Figure 19 Solid Organ Transplantation Procedures Performed Across Major Countries, 2016
Figure 20 Reagents & Consumables to Dominate the Market During the Forecast Period (2018-2023)
Figure 21 PCR-Based Molecular Assays Segment to Dominate the Transplant Diagnostics Market During the Forecast Period
Figure 22 Kidney Segment to Account for the Largest Share of the Market in 2018
Figure 23 Infectious Disease Testing to Dominate the Market During the Forecast Period
Figure 24 Independent Reference Laboratories to Register the Highest CAGR in the Transplant Diagnostics Market During 2018-2023
Figure 25 North America: Market Snapshot (2018-2023)
Figure 26 Solid-Organ Transplantations Performed in the Us, 2013-2017
Figure 27 Tissue Transplantations Performed in the Us, 2013-2017
Figure 28 Solid-Organ Transplantations Performed in Canada, 2015 vs 2016
Figure 29 Europe: Transplant Diagnostics Market Snapshot (2018-2023)
Figure 30 Asia Pacific: Market Snapshot (2018-2023)
Figure 31 Solid-Organ Transplantations Performed in Japan, 2013 to 2017
Figure 32 RoW: Transplant Diagnostics Market Snapshot (2018-2023)
Figure 33 Product Launches and Enhancements, Key Growth Strategies Adopted By Market Players From 2014 to 2018
Figure 34 Bio-Rad Laboratories Held the Leading Position in the Global Transplant Diagnostics Market as of 2017
Figure 35 Geographic Revenue Mix of the Top Five Market Players (2017)
Figure 36 Becton, Dickinson and Company: Company Snapshot (2017)
Figure 37 Biomerieux: Company Snapshot (2017)
Figure 38 Bio-Rad Laboratories: Company Snapshot (2017)
Figure 39 Caredx: Company Snapshot (2017)
Figure 40 F. Hoffman-La Roche Limited: Company Snapshot (2017)
Figure 41 Hologic: Company Snapshot (2017)
Figure 42 Illumina: Company Snapshot (2017)
Figure 43 Immucor: Company Snapshot (2016)
Figure 44 Luminex: Company Snapshot (2017)
Figure 45 Merck KGaA: Company Snapshot (2017)
Figure 46 Qiagen: Company Snapshot (2017)
Figure 47 Thermo Fisher Scientific: Company Snapshot (2017)

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
5 of 5
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories
  • Biofortuna
  • Biomérieux SA
  • Caredx
  • F. Hoffman-La Roche Limited
  • Gendx
  • Hologic
  • Illumina
  • Immucor
  • Luminex
  • Merck KGaA
  • Omixon
  • Qiagen
  • Thermo Fisher Scientific
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll